BridgeBio

BridgeBio

Biotechnology Research

Palo Alto, California 43,543 followers

Hope Through Rigorous Science

About us

BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. BridgeBio creates a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.

Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
Palo Alto, California
Type
Public Company
Founded
2014

Locations

Employees at BridgeBio

Updates

Similar pages

Browse jobs

Funding

BridgeBio 13 total rounds

Last Round

Post IPO equity

US$ 250.0M

See more info on crunchbase